DarioHealth Q4 Earnings Call Highlights

DarioHealth logo DarioHealth is an AI-Powered Digital Therapeutics Play DarioHealth (NASDAQ:DRIO) executives highlighted record commercial momentum and continued cost reductions on the company’s fourth-quarter and year-end 2025 earnings call, while also addressing the revenue impact of a single legacy customer non-renewal and outlining expectations for accelerating growth through 2026. Record new agreements, but full-year revenue declined Chief Executive Officer Erez Raphael said 2025 was the compa ...